In late July 2023, the federal Section of Overall health and Human Products and services publicly encouraged that cannabis be reclassified as a Timetable III compound. This reclassification would make it possible for researchers to submit an application for federal grant revenue and greatly broaden their attempts to learn more in regards to the med